BI 660848

Drug Profile

BI 660848

Latest Information Update: 28 Feb 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim
  • Class Analgesics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Neuropathic pain

Most Recent Events

  • 14 Feb 2011 Boehringer Ingelheim terminates phase I trial in Neuropathic pain in Germany (NCT01145014)
  • 05 Nov 2010 Suspended - Phase-I for Neuropathic pain in Germany (PO, immediate release)
  • 05 Nov 2010 Suspended - Phase-I for Neuropathic pain in Germany (PO, liquid)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top